LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

 

Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)

 

Linda Elsegood - LDN, MS, The LDN Research Trust and Me (2019 Conference) (LDN, low dose naltrexone)

Linda Elsegood, Trustee of the LDN Research Trust, discusses why LDN isn’t widely prescribed, content on the LDN Research Trust website, The LDN Book, and what’s next for the Trust.

 

Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

 

Amy Lamb, Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN (2019 Conference) (LDN, low dose naltrexone)

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today. 

Annie (2)  - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Annie from England who has multiple sclerosis? 

Good morning, Annie. Could you tell us when you were diagnosed with MS?  

Zora - Trinidad: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Zora from Trinidad shares her Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.